Our study aimed to investigate the role of Nrf2 and NF-κB in diabetic neuropathy and to summarize the therapeutic outcomes of moxibustion targeted at Nrf2–NF-κB in diabetic neuropathy. The gene discussed is NFE2L2; the disease is diabetic neuropathy.